₹1,719.55 85.95 (5.26%)
04:01 PM, 3-Jul-2025₹1,718.60 87.30 (5.35%)
03:46 PM, 3-Jul-2025BSE : 540596
NSE : ERIS
Sector : Health care
ISIN Code : INE406M01024
Last Updated: 03-Jul-2025 | 09:31 PM IST
Market Cap (₹ Cr.) | 23,420 |
Traded Value (₹ Cr) | 3.65 |
Volume (Shares) | 21,217 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,909.55 |
52-Week High Date | 12-Jun-2025 |
52-Week Low (₹) | 988.95 |
52-Week Low Date | 15-Jul-2024 |
All Time High (₹) | 1,909.55 |
All Time High Date | 12-Jun-2025 |
All Time Low (₹) | 341.05 |
All Time Low Date | 30-Mar-2020 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr.) | 23,407 |
EPS - TTM (₹) [C] | 25.83 |
P/E Ratio (X) [C] | 66.54 |
Face Value (₹) | 1 |
Latest Dividend (%) | 735.00 |
Latest Dividend Date | 13-Feb-2025 |
Dividend Yield (%) | 0.43 |
Book Value Share (₹) [C] | 209.58 |
P/B Ratio (₹) [C] | 8.20 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Franklin India Pension Plan - (G) | 3.75 | 20,888 | 0.72 |
Franklin India Pension Plan - (IDCW) | 3.75 | 20,888 | 0.72 |
Franklin India Pension Plan - Direct (G) | 3.75 | 20,888 | 0.72 |
Franklin India Pension Plan - Direct (IDCW) | 3.75 | 20,888 | 0.72 |
ICICI Pru All Seasons Bond Fund - Regular (G) | 106.44 | 10,450 | 0.71 |
ICICI Pru All Seasons Bond Fund - Direct (G) | 106.44 | 10,450 | 0.71 |
ICICI Pru All Seasons Bond Fund - Regular (G) | 102.06 | 10,050 | 0.68 |
ICICI Pru All Seasons Bond Fund - Direct (G) | 102.06 | 10,050 | 0.68 |
Bank of India Multi Asset Allocation Fund-Reg (G) | 1.80 | 10,000 | 0.50 |
Bank of India Multi Asset Allocation Fund-Reg (IDCW) | 1.80 | 10,000 | 0.50 |
Load more
Today's Low/High (₹) | 1,610.50 1,735.90 |
Week Low/High (₹) | 1,608.60 1,735.90 |
Month Low/High (₹) | 1,550.10 1,910.00 |
Year Low/High (₹) | 987.10 1,910.00 |
All time Low/High (₹) | 341.05 1,910.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 6.16% | 6.22% | -0.62% | -0.56% |
1 Month | 7.10% | 7.16% | 3.10% | 3.52% |
3 Month | 25.68% | 25.61% | 9.10% | 9.27% |
6 Month | 32.36% | 32.47% | 5.07% | 5.83% |
1 Year | 64.85% | 64.74% | 4.07% | 4.61% |
3 Year | 163.17% | 163.00% | 57.33% | 61.28% |
Chairman & Managing Director : Amit Indubhushan Bakshi
Whole-time Director : Kaushal Kamlesh Shah
Whole-time Director : Inderjeet Singh Negi
Whole Time Director & COO : Krishnakumar Vaidyanathan
Independent Non Exe. Director : Sujesh Vasudevan
Independent Non Exe. Director : Prashant Gupta
Independent Non Exe. Director : Rajeev Narotam Dalal
Independent Non Exe. Director : Kalpana Unadkat
Company Sec. & Compli. Officer : Milind Talegaonkar
Registered Office: 8th Floor Commerce House -IV, Prahladnagar 100 FT Road,Ahmedabad,Gujarat-380015 Ph: 91-79-30451000
1. What's the ERIS Lifesciences Ltd share price today?
ERIS Lifesciences Ltd share price was Rs 1,719.55 at 04:01 PM IST on 3rd Jul 2025. ERIS Lifesciences Ltd share price was up by 5.26% over the previous closing price of Rs 1,633.60. ERIS Lifesciences Ltd share price trend:
2. How can I quickly analyse the performance of the ERIS Lifesciences Ltd stock?
The performance of the ERIS Lifesciences Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of ERIS Lifesciences Ltd?
ERIS Lifesciences Ltd has a market capitalisation of Rs 23,420 crore.
4. What is ERIS Lifesciences Ltd's 52-week high/low share price?
The ERIS Lifesciences Ltd’s 52-week high share price is Rs 1,909.55 and 52-week low share price is Rs 988.95.
5. Is the ERIS Lifesciences Ltd profitable?
On a consolidated basis, ERIS Lifesciences Ltd reported a profit of Rs 102.35 crore on a total income of Rs 713.31 crore for the quarter ended 2025. For the year ended 2023, ERIS Lifesciences Ltd had posted a profit of Rs 374.16 crore on a total income of Rs 1,685.15 crore.
6. Which are ERIS Lifesciences Ltd’s peers in the Health care sector?
ERIS Lifesciences Ltd’s top 5 peers in the Health care sector are Pfizer, J B Chemicals &, Emcure Pharma, ERIS Lifescience, OneSource Speci., Astrazeneca Phar, Alembic Pharma.
7. Who owns how much in ERIS Lifesciences Ltd?
Key changes to the ERIS Lifesciences Ltd shareholding are as follows: